Dr. Peng Chen
Claim this profileTianjin Medical University Cancer Institute & Hospital
Studies Prostate Cancer
Studies Lung Cancer
6 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Peng Chen is currently running
Middle Meningeal Artery Embolization
for Subdural Hematoma
The purpose of this study is to evaluate the safety and efficacy of embolization of the middle meningeal artery (MMA) using the Onyx™ Liquid Embolic System (LES) for treatment of symptomatic subacute or chronic subdural hematoma (SDH)
Recruiting1 award N/A4 criteria
Fuzuloparib + AA-P
for Prostate Cancer
This trial is testing whether a combination of Fuzuloparib and AA-P is better for treating advanced prostate cancer. The treatment aims to kill cancer cells by preventing them from fixing their damaged DNA and by reducing hormone levels that help the cancer grow. The study includes patients with and without specific DNA repair deficiencies.
Recruiting1 award Phase 37 criteria
More about Peng Chen
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Peng Chen has experience with
- Prednisone
- Abemaciclib
- Onyx™ Liquid Embolic System
- Surgical Management
- SKB264
- Abiraterone Acetate
Breakdown of trials Peng Chen has run
Prostate Cancer
Lung Cancer
Subdural Hematoma
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peng Chen specialize in?
Peng Chen focuses on Prostate Cancer and Lung Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Peng Chen currently recruiting for clinical trials?
Yes, Peng Chen is currently recruiting for 2 clinical trials in Tianjin Tianjin. If you're interested in participating, you should apply.
Are there any treatments that Peng Chen has studied deeply?
Yes, Peng Chen has studied treatments such as Prednisone, Abemaciclib, Onyx™ Liquid Embolic System.
What is the best way to schedule an appointment with Peng Chen?
Apply for one of the trials that Peng Chen is conducting.
What is the office address of Peng Chen?
The office of Peng Chen is located at: Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin 300060 China. This is the address for their practice at the Tianjin Medical University Cancer Institute & Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.